Validity of A Portable EKG Device to Monitor Heart Rate and Rhythm in College-aged Male Athletes
Main Article Content
Keywords
sudden cardiac death, electrocardiogram, wearable technology
Abstract
Introduction: Sudden cardiac death (SCD) is the leading medical cause of death for male athletes, especially in anaerobic-based sports. Standard 12-lead electrocardiograms (STD-ECG) have received recent attention for their diagnostic utility, but lack the practicality for mass screenings. The purpose of this investigation was to assess the validity of a compact HD-EKG unit during various testing environments: rest, aerobic activity, and immediate recovery of anaerobic activity in college-age, male athletes. Methods: Twelve college-aged (19.9 ± 1.1 years old), male athletes volunteered. Test procedures included two ECG devices, a STD-ECG and a high-definition (HD-) EKG, simultaneously recording heart rate (HR) and rhythms during rest, a single-stage walking test, and during recovery of the Wingate Anaerobic Power test.
Results: Paired t-tests did not detect differences between measures of HR and rhythm (t(47) = -0.71, p > 0.05 and t(4) = 0.82, p > 0.05, respectively). The two measures of HR were very strongly related (r = 0.98, p < 0.001). However, the absolute difference between the STD-ECG and HD-EKG averaged 3.47 ± 4.44 bpm, which is significantly different than the acceptable variance of ± 2 bpm.
Conclusions: Wearable technology, such as a portable HD-EKG device worn during vigorous anaerobic activity, such as the Wingate Anaerobic Power test, may identify athletes most at risk for SCD.
References
2. Harmon KG, Asif IM, Klossner D, Drezner JA. Incidence of sudden cardiac death in National Collegiate Athletic Association Athletes. Circulation. 2011;123(15):1594-1600.
3. Asif IM, Harmon KG. Incidence and etiology of sudden cardiac death: New updates for athletic departments. Sports Health. 2017;9(3):268-279.
4. Maron BJ, Thompson PD, Ackerman MJ, et al. Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation. Circulation. 2007;115(12):1643-1455.
5. Harmon KG, Asif IM, Maleszewski JJ, et al. Incidence, cause, and comparative frequency of sudden cardiac death in National Collegiate Athletic Association Athletes: A decade in review. Circulation. 2015;132(1):10-19.
6. Sessa F, Anna V, Messina G, et al. Heart rate variability as predictive factor for sudden cardiac death. Aging . 2018;10(2):166-177.
7. Hillebrand S, Gast KB, de Mutsert R, et al. Heart rate variability and first cardiovascular event in populations without known cardiovascular disease: meta-analysis and dose-response meta-regression. Europace. 2013;15(5):742- 749.
8. Maranesi E, Morettini M, Agostinelli A, Giuliani C, Di Nardo F, Burattini L. Health monitoring in sport through wearable sensors: A novel approach based on heart-rate variability. In: Lecture Notes in Electrical Engineering. ; 2016:235-246.
9. ACSM. ACSM’s Guidelines for Exercise Testing and Prescription. Lippincott Williams & Wilkins; 2014.
10. Pickering TG, Hall JE, Appel LJ, et al. Recommendations for blood pressure measurement in humans: An AHA Scientific Statement from the Council on High Blood Pressure Research Professional and Public Education Subcommittee. J Clin Hypertens. 2005;7(2):102-109.
11. Jackson AS, Pollock ML. Practical assessment of body composition. Phys Sportsmed. 1985;13(5):76-90.
12. Lohmann TG, Roche AF, Martorell R. Anthropometric Standardization Reference Manual. Human Kinetics; 1988.
13. Heyward VH. Advanced Fitness Assessment and Exercise Prescription. Human Kinetics Publishers; 2010.
14. Mason RE, Likar I. A new system of multiple-lead exercise electrocardiography. Am Heart J. 1966;71(2):196-205.
15. Ebbeling CB, Ward A, Puleo EM, Widrick J, Rippe JM. Development of a single-stage submaximal treadmill walking test. Med Sci Sports Exerc. 1991;23(8):966-973.
16. Zupan MF, Arata AW, Dawson LH, Wile AL, Payn TL, Hannon ME. Wingate Anaerobic Test peak power and anaerobic capacity classifications for men and women intercollegiate athletes. J Strength Cond Res. 2009;23(9):2598-2604.
17. Bland JM, Martin Bland J, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Int J Nurs Stud. 2010;47(8):931-936.
18. Giles D, Draper N, Neil W. Validity of the Polar V800 heart rate monitor to measure RR intervals at rest. Eur J Appl Physiol. 2016;116(3):563-571.
19. Weippert M, Kumar M, Kreuzfeld S, Arndt D, Rieger A, Stoll R. Comparison of three mobile devices for measuring R-R intervals and heart rate variability: Polar S810i, Suunto t6 and an ambulatory ECG system. Eur J Appl Physiol. 2010;109(4):779-786.
20. Walsh JA 3rd, Topol EJ, Steinhubl SR. Novel wireless devices for cardiac monitoring. Circulation. 2014;130(7):573-581.
21. Kobayashi H. Effect of measurement duration on accuracy of pulse- counting. Ergonomics. 2013;56(12):1940-1944.
22. Lampert R. Evaluation and management of arrhythmia in the athletic patient. Prog Cardiovasc Dis. 2012;54(5):423-431.
23. Patel DA, Lavie CJ, Milani RV, Shah S, Gilliland Y. Clinical implications of left atrial enlargement: A review. Ochsner J. 2009;9(4):191-196.
24. Prior DL, La Gerche A. The athlete’s heart. Heart. 2012;98(12):947-955.
25. Rawshani DA. The ECG in left ventricular hypertrophy (LVH): criteria and implications – ECG learning. ECG learning. https://ecgwaves.com/ecg- left-ventricular-hypertrophy-lvh-clinical-characteristics/. Published April 4,
2017. Accessed August 4, 2018.
